| Epidemiology from Literature | | Cohort | Year | Country | Test | Subjects | Positive (%) | Bibliography | | 1.9 - Pollen Allergy | 2014 | Czech Republic | IgE | 826 | 4.200 | 20140606, Panzner P
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Austria | IgE | 217 | 21.000 | 20141002, Deifl S
| | 1.11 - Esophagitis, Diagnosed | 2014 | Spain | IgE | 67 | 1.500 | 20140625, Armentia A
| | 1.1 - Asymptomatic | 2014 | Spain | IgE | 50 | 0.000 | 20140625, Armentia A
| | 1.9 - Pollen Allergy | 2014 | Spain | IgE | 50 | 2.000 | 20140625, Armentia A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 37 | 0.000 | 20140127, Konradsen JR
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2014 | Sweden | IgE | 28 | 0.000 | 20140127, Konradsen JR
| | 1.11 - Esophagitis, Diagnosed | 2013 | Netherlands | IgE | 76 | 1.300 | 20131020, van Rhijn BD
| | 1.11 - Esophagitis, Diagnosed | 2013 | Switzerland | IgE | 35 | 2.860 | 20130605, Simon D
| | 6.2 - General Population (Adults) | 2012 | Sweden | IgE | 371 | 0.270 | 20120528, Patelis A
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2012 | Belgium | IgE | 99 | 3.030 | 20110223, De Knop KJ
| | 1.2.1 - Asthma, Diagnosed (Adults) | 2012 | Sweden | IgE | 96 | 4.170 | 20120528, Patelis A
| | 10.1 - Normal Control | 2012 | Belgium | IgE | 27 | 0.000 | 20110223, De Knop KJ
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2011 | Italy | IgE | 148 | 18.240 | 20110810, Pastorello EA
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2010 | Czech Republic | IgE | 178 | 14.600 | 20101026, Sekerkova A
| | 1.10 - Any allergy symptom, Diagnosed | 2010 | Belgium | IgE | 86 | 12.790 | 20101214, Gadisseur R
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Belgium | IgE | 37 | 5.405 | 20090826, Ebo DG
| | 10.1 - Normal Control | 2009 | Belgium | IgE | 26 | 0.000 | 20091121, Ebo DG
| | 4.1.7 - Heterologous Source Sensitized (Symptoms, SPT, IgE) | 2009 | Switzerland | IgE | 24 | 8.000 | 20091005, Bauermeister K
| | 4.1.4 - Heterologous Source Sensitized (Symptoms, IgE) | 2009 | Belgium | IgE | 22 | 0.000 | 20091121, Ebo DG
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2009 | Belgium | IgE | 20 | 15.000 | 20091121, Ebo DG
| | 1.5 - Atopic Dermatitis, Diagnosed | 2009 | Germany | IgE | 20 | 10.000 | 20091005, Ott H
| | 5.3.1 - Source Exposed (Symptoms, IgE) | 2009 | Switzerland | IgE | 20 | 5.000 | 20091005, Bauermeister K
| | 4.1.5 - Heterologous Source Sensitized (IgE) | 2008 | Italy | IgE | 246 | 10.000 | 20080613, Wopfner N
| | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2008 | Germany | IgE | 50 | 4.000 | 20081129, Treudler R
| | 3.2.1 - Source Sensitized (IgE) | 2005 | Finland | IgE | 55 | 7.000 | | | 3.2.1 - Source Sensitized (IgE) | 2005 | Russian Federation | IgE | 5 | 0.000 | | | 5.3.1 - Source Exposed (Symptoms, IgE) | 2003 | Italy | IgE | 372 | 9.400 | | | 3.1.1 - Source Sensitized (SPT) | 2003 | Italy | IgE | 370 | 17.600 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | France | IgE | 50 | 6.000 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Austria | IgE | 45 | 11.000 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Finland | IgE | 39 | 5.000 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Sweden | IgE | 37 | 8.000 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Switzerland | IgE | 28 | 7.000 | | | 5.4.1 - Source Exposed (Symptoms, SPT, IgE) | 2002 | Italy | IgE | 11 | 27.000 | | | 4.1.8 - Heterologous Source Sensitized (SPT, IgE) | 1997 | Austria | IgE | 112 | 20.000 | |
|
Loading...
Bet v 4
